ANG Lifesciences India Ltd
NSE: BSE: 540694
₹36.17
(4.99%)
Sun, 18 Oct 2026, 08:32 pm
Market Cap (in Cr)42.84
PE Ratio0
Dividend0
Health Technology
Pharmaceuticals: Major
24.5KANG Lifesciences India Balance Sheet
| Particulars | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
| Interest expense on debt | -18.06M | -26.13M | -31.90M | -33.33M | -94.22M | -124.81M | -114.08M | -90.53M |
| Pretax equity in earnings | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity in earnings | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total assets | 681.65M | 808.98M | 941.26M | 1.44B | 2.91B | 2.78B | 2.42B | 2.30B |
| Total current assets | 468.75M | 599.59M | 727.13M | 1.16B | 1.93B | 1.83B | 1.73B | 1.61B |
| Cash and short term investments | 14.79M | 43.71M | 36.01M | 38.63M | 66.52M | 61.77M | 57.35M | 36.36M |
| Cash & equivalents | 14.79M | 43.71M | 36.01M | 38.63M | 3.46M | 3.24M | 3.19M | 1.57M |
| Short term investments | 0 | 0 | 0 | 0 | 63.06M | 58.53M | 54.17M | 34.78M |
| Total receivables, net | 348.95M | 445.64M | 495.97M | 644.88M | 1.03B | 846.67M | 740.85M | 675.29M |
| Accounts receivable - trade, net | 321.50M | 417.49M | 460.64M | 587.43M | 1.02B | 831.48M | 732.77M | 665.39M |
| Other receivables | 27.45M | 28.15M | 35.32M | 57.44M | 10.82M | 15.19M | 8.08M | 9.90M |
| Total inventory | 83.79M | 78.96M | 161.72M | 218.94M | 463.20M | 540.23M | 591.49M | 581.85M |
| Other current assets, total | 20.41M | 24.42M | 31.51M | 253.44M | 363.99M | 379.42M | 341.33M | 315.33M |
| Total non-current assets | 212.91M | 209.39M | 214.13M | 278.96M | 982.18M | 945.09M | 691.25M | 685.64M |
| Long term investments | 200.00K | 200.00K | 200.00K | 35.20M | 9.05M | 257.00K | 257.00K | 257.00K |
| Note receivable - long term | — | — | — | — | 8.79M | 0 | — | — |
| Investments in unconsolidated subsidiaries | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other investments | 200.00K | 200.00K | 200.00K | 35.20M | 257.00K | 257.00K | 257.00K | 257.00K |
| Net property/plant/equipment | 210.41M | 207.59M | 209.37M | 238.65M | 928.46M | 883.79M | 586.28M | 574.24M |
| Gross property/plant/equipment | 315.64M | 324.06M | 337.29M | 379.74M | 1.42B | 1.47B | 1.20B | 1.24B |
| Deferred tax assets | — | — | 511.25K | 1.14M | 42.85M | 41.20M | 44.59M | 63.72M |
| Net intangible assets | — | — | 2.31M | 2.31M | — | — | — | — |
| Goodwill, net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other intangibles, net | — | — | 2.31M | 2.31M | — | — | — | — |
| Other long term assets, total | 2.29M | 1.59M | 1.74M | 1.66M | 1.83M | 19.85M | 60.12M | 47.42M |
| Short term debt | 63.99M | 124.14M | 155.83M | 361.32M | 553.58M | 499.48M | 561.14M | 624.76M |
| Current portion of LT debt and capital leases | 0 | 0 | 26.64M | 31.93M | 0 | 50.20M | 57.89M | 65.93M |
| Short term debt excl. current portion of LT debt | 63.99M | 124.14M | 129.19M | 329.39M | 553.58M | 449.29M | 503.25M | 558.83M |
| Accounts payable | 223.15M | 218.15M | 257.90M | 400.40M | 706.29M | 681.86M | 661.79M | 660.74M |
| Income tax payable | 10.00M | 22.00M | 24.00M | 50.47M | 189.11M | 176.63M | 42.63M | 758.00K |
| Long term debt | 76.83M | 62.78M | 52.50M | 70.29M | 216.37M | 208.00M | 167.22M | 207.30M |
| Long term debt excl. lease liabilities | 76.83M | 62.78M | 52.50M | 70.29M | 216.37M | 208.00M | 167.22M | 207.30M |
| Total equity | 231.68M | 287.67M | 345.55M | 415.83M | 837.69M | 862.18M | 762.77M | 639.76M |
| Shareholders' equity | 231.68M | 287.67M | 345.55M | 415.83M | 837.69M | 862.18M | 762.77M | 639.76M |
| Common equity, total | 231.68M | 287.67M | 345.55M | 415.83M | 837.69M | 862.18M | 762.77M | 639.76M |
| Other common equity | 1.00M | 500.00K | 0 | 0 | 49.91M | 49.91M | 49.91M | 49.91M |
| Total debt | 140.82M | 186.92M | 208.33M | 431.61M | 769.95M | 707.48M | 728.37M | 832.06M |
| Net debt | 126.03M | 143.21M | 172.32M | 392.98M | 703.43M | 645.71M | 671.01M | 795.71M |
| Change in accounts receivable | -65.94M | -95.98M | -43.15M | -126.79M | -452.18M | 179.31M | 114.22M | 62.86M |
| Change in taxes payable | — | — | — | — | — | — | — | — |
| Change in accounts payable | 9.23M | -5.01M | 39.75M | 142.51M | 253.31M | -22.21M | -44.03M | -5.92M |
| Change in other assets/liabilities | 19.73M | 11.97M | -17.16M | -144.34M | -74.65M | 23.32M | -130.08M | 68.70M |
| Sale of fixed assets & businesses | 0 | 0 | 0 | 0 | 0 | 0 | 244.96M | 0 |
| Purchase/sale of investments, net | 0 | 0 | 0 | -35.00M | -34.34M | 4.53M | 4.37M | 19.38M |
| Sale/maturity of investments | 0 | 0 | 0 | 0 | 0 | 4.53M | 4.37M | 19.38M |
| Purchase of investments | 0 | 0 | 0 | -35.00M | -34.34M | 0 | 0 | 0 |
| Other investing cash flow items, total | -1.41M | 700.64K | 0 | 492.00K | 780.00K | 205.00K | 0 | 0 |
| Issuance/retirement of debt, net | 25.06M | 46.10M | -5.23M | 217.99M | 289.22M | -70.15M | 13.06M | 111.88M |
| Issuance/retirement of long term debt | 27.20M | -14.06M | -10.28M | 17.79M | 114.08M | -53.60M | -40.91M | 56.30M |
| Issuance/retirement of short term debt | -2.15M | 60.16M | 5.05M | 200.19M | 175.14M | -16.55M | 53.97M | 55.58M |
| Issuance/retirement of other debt | — | — | — | — | — | — | — | — |
| Total cash dividends paid | 0 | 0 | 0 | 0 | -10.35M | 0 | 0 | 0 |
| Other financing cash flow items, total | -500.00K | -500.00K | -500.00K | 0 | 0 | 0 | 0 | 0 |
